Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nobuko Sugimoto is active.

Publication


Featured researches published by Nobuko Sugimoto.


Microbiology and Immunology | 1990

Induction of Interferons (IFNs) and Tumor Necrosis Factor (TNF) in Mice by a Novel Glycolipid Trehalose 2, 3, 6'-Trimycolate from Rhodococcus aurantiacus (Gordona aurantiaca)

Takako Fujita; Nobuko Sugimoto; Fusa Yokoi; Yoshikazu Ohtsubo; Masatoshi Ikutoh; Yoshiko Kato; Yayoi Natsuhara; Shiro Oka; Ikuya Yano

The immunomodifying activity of a novel mycoloyl glycolipid, trehalose 2,3,6′‐trimycolate (GaGM), from a unique psychrophilic acid‐fast bacterium, Rhodococcus aurantiacus, was examined. ICR mice were primed intravenously (i.v.) or intraperitoneally (i.p.) with liposomes containing GaGM (300 μg/mouse), and were administered LPS dissolved in saline (25 μg/mouse, i.v.) 2 weeks later. Two hours after injection of LPS, interferons (IFNs) and tumor necrosis factor (TNF) were induced significantly in mice sera. The increase in activities of IFNs and TNF was approximately paralleled with granuloma formation in spleen of mice primed with GaGM. However, IFNs and TNF were not induced either in mice primed with GaGM but not elicited with LPS, or in those primed with GaGM and elicited by GaGM. Both activities induced were lower in mice primed with trehalose mono‐ or dimycolate from R. aurantiacus (GaTMM, GaTDM) or TDM from Nocardia rubra than in GaGM‐primed mice. Time course study showed that the maximum activity of each interferon (α, β, or γ) was observed at different stages after LPS administration; IFN‐α, IFN‐β, and IFN‐γ appeared 3, 2, and 6 hours most abundantly after LPS administration, respectively.


Archive | 1995

Antipyretic and analgesic agent

Masumi Furukawa; Masaya Hizaki; Masahisa Kakimoto; Rika Koyama; Yuka Sakata; Yoshiaki Shinohara; Nobuko Sugimoto; ますみ 古川; 由佳 坂田; 興志一 多田; 理香 小山; 信子 杉本; 正久 柿本; 雅也 樋崎; 芳明 篠原


Journal of pharmacobio-dynamics | 1987

Isolation of mycolic acid-containing glycolipids in Nocardia rubra and their granuloma forming activity in mice

Ikuya Yano; Ikuko Tomiyasu; Kenji Kaneda; Yoshiko Kato; Yukie Sumi; Satoko Kurano; Nobuko Sugimoto; Hiroyuki Sawai


Archive | 1987

N-tetrazolyl thiazolecarboxyamide derivatives and their use

Junji Yoshinaga; Takeshi Shoyaki; Takao Kakita; Hiromi Ozeki; Nobuko Sugimoto; Yoshiko Kato


Archive | 1987

N-tetrazolyl thiazolecarboxamide derivatives and their use

Junji Yoshinaga; Takeshi Shogaki; Takao Kakita; Hiromi Ozeki; Nobuko Sugimoto; Yoshiko Kato


Fems Microbiology Letters | 1990

Induction of tumoricidal activated macrophages by a liposome-encapsulated glycolipid, trehalose 2,3,6,′-trimycolate from Gordona aurantiaca

Masumi Furukawa; Yoshikazu Ohtsubo; Nobuko Sugimoto; Yoshiko Katoh; Yoshitame Dohi


Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 1987

Newly isolated glycolipids from Rhodococcus terrae cell wall and their granuloma forming activities

Satoko Kurano; Nobuko Sugimoto; Yukie Sumi; Hiroyuki Sawai; Yoshiko Kato; Kenji Kaneda; Ikuya Yano


Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 1989

[Granuloma formation in mice by liposomes of new glycolipid containing mycolic acids, "trehalose 2,3,6'-trimycolate"].

Fusa Yokoi; Nobuko Sugimoto; Keiko Kato; Kenji Kaneda; Shiro Oka; Ikuya Yano


Japanese journal of bacteriology | 1989

An immune adjuvant activity of mycolic acid-containing glycolipid, trehalose-2,3,6'-trimycolate, derived from Gordona aurantiaca.

Yoshikazu Ohtsubo; Masumi Furukawa; Yumiko Fujinobu; Nobuko Sugimoto; Masatoshi Ikutoh; Yoshiko Katoh; Ikuya Yano; Minoru Higasa; Sohei Shinka; Yoshitane Dohi


The Journal of the Japanese Association for Infectious Diseases | 1988

Protective Effect of Glycolipid Containing Mycolic Acid Derived from Gordona aurantiaca Against Yersinia enterocolitica

Takako Fujita; Kawata Y; Kitamura F; Nobuko Sugimoto; Ikuya Yano; Sawai H; Kato Y; Miyama A

Collaboration


Dive into the Nobuko Sugimoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shiro Oka

Osaka City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Minoru Higasa

Hyogo College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sohei Shinka

Hyogo College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge